Charlotte Cox Email and Phone Number

Business Development Director supporting clients in Europe and The Middle East at Altasciences. Owned by Novo Holdings and headquartered in Canada, Altasciences is an integrated, full-service CRO / CDMO with 9 facilities across North America. Altasciences partners with sponsors to provide support for preclinical safety assessment, bioanalysis, clinical pharmacology and proof of concept, manufacturing and research support services. Our clinical trial facilities include adaptive Phase 1 and 2 clinical pharmacology units for healthy normal participant and patient population studies, as well as capabilities for specialised assessments including driving simulation and human abuse potential studies. We support the development of our sponsors' assets and have experience across a diverse range of test items including small molecules, large molecules, cell and gene therapies, antibodies, biosimilars, oligonucleotides amongst others.

Manager at Charles River of the Safety Assessment, Pharma Sales team covering the UK and Ireland.

Associate Business Development Manager covering the UK and Ireland for Safety Assessment, Pharma at Charles River. Charles River is one of the largest preclinical Contract Research Organizations with a strong portfolio across Research Models and Services, Discovery, Safety Assessment, Biologics and Microbial Solutions. I have a global overview of the 20+ Safety Assessment sites and have experience supporting a range of clients in the areas of small molecules, antibodies, vaccines, biosimilars, peptides, medical devices and cell and gene therapies for a variety of dose routes and indications. I support stand-alone safety assessment studies as well as complete IND-enabling programs. My aim is to ensure efficient and exemplary drug safety testing for clients.

Using my background in life sciences and finance, I wrote a number of articles for the scientific community and wider public. I mentored university students on writing style and communication.

Administrator working on both the investment banking and trading floors. I rotated across various divisions including; mergers and acquisitions, healthcare, industrials, consumer retail and capital markets. I collated client reports from equity research, transcripts of meetings, press research and quarterly performance reviews to put together public information books. Using this information, I created presentations for Managing Directors to pitch future mergers and acquisitions to their clients.